Has Russia successfully made the first vaccine for covid-19? Here’s what you need to know

There is a major spike in covid-19 cases globally and only a vaccine can get us out of this situation. It seems Russia is taking the lead on that front.
Has Russia got a solve for covid-19? Image courtesy: Shutterstock
Team Health Shots Updated: 13 Jul 2020, 13:17 pm IST
  • 79

It looks like Russia is going to be the frontrunner in the making of the world’s first covid-19 vaccine. The news is that the clinical trials of the world’s first coronavirus vaccine on volunteers at Sechenov First Moscow State Medical University have been successfully completed.

According to the Russian news agency, Sputnik, Vadim Tarasov, the director of the Institute for Translational Medicine and Biotechnology said that the first group of volunteers would be discharged on 15th July and the second on 20th July.

“Sechenov University has successfully completed tests on volunteers of the world’s first vaccine against coronavirus,” Tarasov said.

The university began clinical trials of the vaccine produced by Russia’s Gamalei Institute of Epidemiology and Microbiology on June 18.

The good news is that according to Russian authorities this vaccine is also safe
Although the trials are still on, but according to Alexander Lukashev, the director of the Institute of Medical Parasitology, Tropical and Vector-Borne Diseases at Sechenov University, the objective of this stage of the study was to show the vaccine’s safety for human health, which was successfully done.

Lukashev told Sputnik:

The safety of the vaccine is confirmed. It corresponds to the safety of those vaccines that are currently on the market.

Currently, there are 21 vaccines under key trials, according to the WHO
Gilead Sciences, Oxford University, and American Biotech Company Moderna are some foreign frontrunners in the development of the covid-19 vaccine. However for Gilead Sciences more clinical trials are required to see the benefits of the vaccine.

According to reports BioNTech SE and Pfizer Inc’s covid-19 vaccine candidate is expected to be ready to seek regulatory approval by the end of 2020.

When it comes to Indian companies Bharat Biotech is all set for the first human trial of the covid-19 vaccine–Covaxin. 

Select Topics of your interest and let us customize your feed.

PERSONALISE NOW
Let’s hope to get covid-19 vaccine by end of the 2020. Image courtesy: Shutterstock

The Indian Council of Medical Research (ICMR) DG Balram Bhargava has written a letter to Bharat Biotech and principal investigators of medical colleges to complete the trial procedure of the indigenous covid-19 vaccine in a fast track method, so that results of a clinical trial can be launched by August 15. 

So, let’s hope we hear some positive updates about the SARS-CoV-2 vaccine real soon. 

 (With inputs from ANI)

  • 79
About the Author

We are a varied group of Health Shots writers, bringing you the healthiest scoop on wellness in town. ...Read More

Healthshots Wellness Newsletter

Get your Daily Dose of Wellness in your Inbox

Subscribe Now
Next Story